Vijaya Diagnostic Centre reported strong growth for the fiscal year ended March 31, 2026. The company achieved INR 8,142 million in annual revenue, reflecting a 19.5% year-on-year increase. Quarterly performance was equally robust, with Q4 FY26 revenue reaching INR 2,194 million and a PAT of INR 479 million. The company continues its strategic expansion, currently operating 162 diagnostic centres across 27 cities and towns in India, supported by an integrated hub-and-spoke model.
Record Financial Performance
Vijaya Diagnostic Centre concluded FY26 with record financial results. The company’s annual revenue from operations crossed the INR 8,000 million milestone, reaching INR 8,142 million, a 19.5% increase compared to the previous year. For Q4 FY26, the company recorded its highest-ever quarterly revenue of INR 2,194 million, representing a 26.6% year-on-year growth. The annual PAT for FY26 stood at INR 1,730 million, demonstrating a healthy 21.2% margin.
Operational Milestones and Growth
As of March 31, 2026, the company operates a robust network of 162 centres. Key operational metrics remain strong, with 16.92 million tests performed throughout the year and total annual footfalls reaching 4.68 million. The company maintains a strong B2C focus, with 92% of its revenue generated from the B2C segment. Management attributed this growth to strong momentum in both pathology and radiology segments, aided by successful network expansion into newer geographies.
Strategic Expansion and Future Outlook
Vijaya Diagnostic continues to execute its expansion strategy, particularly in East India and neighboring states. Following the acquisition of PH in Pune, the company is focusing on densifying its network. Plans for FY27 include the addition of 4–5 new hubs and 10–12 spokes. Additionally, the company is prioritizing technological advancement, including the establishment of a fully automated laboratory in Panjagutta, Hyderabad, and the integration of AI-driven radiology and genomic testing capabilities to enhance diagnostic accuracy and turnaround times.
Source: BSE
